(A Top Pick Aug 13/15. Down 11.51%.) This has been dead quiet over the course of the last year. It had a lift through November-February, and then basically has consolidated ever since. The group is actually starting to look quite interesting. The sector has been improving from a relative strength standpoint, since June. This could still be a Buy at these levels.
It is the largest hospital operator in the U.S. It is a defensive stock with consistent revenue but not consistent costs. It will continue to have issues with this and he wants to see more visibility on costs. It executes well.
A bit contrarian. Not a consensus long. Unique. Largest operator of for-profit hospitals in the US, plus emergency and ambulatory care centres. Key component of healthcare delivery. Executing exceptionally well over 6-7 years. Labour costs have been a drag, but this is abating. Yield is 1.07%. (Analysts’ price target is $257.67)
Healthcare has been a big focus of his. This is the largest hospital management companies in the US, even if only 5% of the market, so there is lots of room for growth. The US population is aging. This is a steady, non-economically sensitive company.
(A Top Pick Aug 13/15. Down 11.51%.) This has been dead quiet over the course of the last year. It had a lift through November-February, and then basically has consolidated ever since. The group is actually starting to look quite interesting. The sector has been improving from a relative strength standpoint, since June. This could still be a Buy at these levels.